ReproCELL, Inc. (JASDAQ:4978) announced that it has entered into agreement for a private placement of 7,000,000 14th series warrants at a price of ¥0.97 per warrant with EVO FUND, a fund managed by Evolution Capital Management, LLC for gross proceeds of ¥6,790,000 on May 25, 2018. each warrant entitles the holder to purchase one common shares of the company at an exercise price of ¥293 per share from June 12, 2018 to October 9, 2018. The warrants will be issued by third party allocation. The company will pay issuance expense of ¥10,650,000. The transaction has been approved by the board of directors of the company. The allotment date is June 11, 2018.